Neurostimulation Devices Market Insights, Opportunity, Analysis, Market Shares & Forecast 2016 – 2021

November 2016 | 115 pages | ID: N4242FA5B06EN
DPI Research

Abstracts

The Global market for Neurostimulation Devices is expected to cross US$5 Billion by the year end of 2021.

Drivers & Restraints

Market growth can be attributed to factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by the players. In addition, rapid advances in the field of neurostimulation and development of minimally invasive techniques have greatly expanded the market. High cost of treatment and negative social perception is restraining the growth of neurostimulation devices Market.

Segment Insights

Spinal cord stimulation segment dominated the neurostimulation devices market with more than XX% share in 2015. But its market share will dwindle in the forecasting period due to the highest growth rate of deep brain stimulation segment. It is expected that deep brain stimulation segment will grab nearly 20% market share by the year end of 2021.

Regional Insights

North America is seen as the dominant player in the neurostimulation devices market followed by Europe, Asia–Pacific, and rest of the world (RoW) in 2015. In the coming years, the neurostimulation devices market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan. These countries are expected to increase revenues for the manufacturers of devices involved in neurostimulation.

Application Insights

Chronic Pain is identified as the largest application segment of the neurostimulation devices market. Urinary and Fecal Incontinence(UFI) is the second leading segment for neurostimulation devices market. Refractory epilepsy stands at the third spot with more than XX% share in 2015. Parkinson’s disease holds the fourth highest share being followed by Gastroparesis. Essential Tremor and Dystonia are the other leading application segment for neurostimulation devices market.

Company Insights

Further, prudent analysis has been done on the competitor’s part, where three major players grab XX% of the global market by revenue. Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro are the key influencers with their products in the neurostimulation devices market. Merger & acquisitions, partnerships, collaborations and extending distribution networks are few important factors for their dominance.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry–validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, application, geographies, companies and market dynamics. The report concludes with the profiles of major players in the global neurostimulation market such as Medtronic, Boston Scientific, St Jude Medical, Liva Nova and Nevro. The major market players are evaluated on various parameters such as company overview, product portfolio, and sales analysis of neurostimulation devices segment from 2010 to 2021. The report also entails major drivers and barriers of neurostimulation devices market.

Neurostimulation Devices Market: Segmentation

Neurostimulation Devices Market is classified on the basis of device segment, application, company and geography.

Based on Segment, Neurostimulation Devices Market can be segmented as follows:

• Spinal Cord Stimulation
• Deep Brain Stimulation
• Sacral Nerve Stimulation
• Vagus Nerve Stimulation
• Other Devices Segment

Based on Application, Neurostimulation Devices Market can be segmented as follows:

• Chronic Pain
• Parkinson’s Disease
• Urinary Fecal Incontinence
• Refractory Epilepsy
• Essential Tremor
• Dystonia
• Gastroparesis
• Treatment Resistant Depression(TRD)
• Obsessive Compulsive Disorder(OCD)
• Other Applications

Based on Geography, Neurostimulation Devices Market can be segmented as follows:

• North America
• Europe
• Asia Pacific
• Latin America
• Rest of the World (ROW)

Based on Company, Neurostimulation Devices Market can be segmented as follows:

• Medtronic
• Boston Scientific
• St Jude Medical
• Liva Nova(Cyberonics)
• Nevro

Contents

1. EXECUTIVE SUMMARY

2. GLOBAL – NEUROSTIMULATION DEVICES MARKET & FORECAST (2010 – 2021)

3. GLOBAL – NEUROSTIMULATION DEVICES MARKET SHARE OUTLOOK

3.1 By Segment – Neurostimulation Devices Market Share Outlook
3.2 By Region – Neurostimulation Devices Market Share Outlook
3.3 By Application – Neurostimulation Devices Market Share Outlook
3.4 By Company – Neurostimulation Devices Market Share Outlook

4. GLOBAL NEUROSTIMULATION DEVICES MARKET – SEGMENT ANALYSIS (2010 – 2021)

4.1 By Segment - Overall Neurostimulation Devices Market & Forecast
4.2 Spinal Cord Stimulation
4.3 Deep Brain Stimulation
4.4 Sacral Nerve Stimulation
4.5 Vagus Nerve Stimulation
4.6 Other Neurostimulation Devices Segment

5. GLOBAL NEUROSTIMULATION DEVICES MARKET – GEOGRAPHICAL ANALYSIS (2010 – 2021)

5.1 By Region – Overall Neurostimulation Devices Market Revenue & Forecast
5.2 North America
5.3 Europe
5.4 Asia Pacific
5.5 Latin America
5.6 Rest of the World (ROW)

6. GLOBAL NEUROSTIMULATION DEVICES MARKET – APPLICATION ANALYSIS (2010 – 2021)

6.1 By Application – Overall Neurostimulation Devices Market Revenue
6.2 Chronic Pain
6.3 Parkinson’s Disease
6.4 Urinary Fecal Incontinence
6.5 Refractory Epilepsy
6.6 Essential Tremor
6.7 Dystonia
6.8 Gastroparesis
6.9 Treatment Resistant Depression(TRD)
6.10 Obsessive Compulsive Disorder(OCD)
6.11 Others Neurostimulation Application

7. MARKET DYNAMICS – MERGERS, ACQUISITIONS & KEY AGREEMENTS, COLLABORATIONS & PARTNERSHIPS

7.1 Mergers & Acquisitions
7.2 Agreements, Collaborations & Partnerships

8. KEY COMPANIES ANALYSIS

8.1 Medtronic
  8.1.1 Business Overview
  8.1.2 Neurostimulation Products Portfolio
    8.1.2.1 Deep Brain Stimulation for Movement Disorders
    8.1.2.2 Deep Brain Stimulation for Psychiatric Disorders
    8.1.2.3 Gastric Electrical Stimulation
    8.1.2.4 Percutaneous Tibial Neurostimulation
    8.1.2.5 Sacral Neurostimulation
    8.1.2.6 Spinal Cord Stimulation
  8.1.3 Neurostimulation Device Sales Analysis & Forecast
8.2 Boston Scientific
  8.2.1 Business Overview
  8.2.2 Neurostimulation Products Portfolio
    8.2.2.1 Spinal Cord Stimulator Systems
    8.2.2.2 Deep Brain Stimulation (DBS) System
  8.2.3 Neurostimulation Device Sales Analysis & Forecast
8.3 St Jude Medical
  8.3.1 Business Overview
  8.3.2 Neurostimulation Products Portfolio
    8.3.2.1 Spinal Cord Stimulation
    8.3.2.2 Dorsal Root Ganglion (DRG) Stimulation
    8.3.2.3 Radiofrequency Therapy
  8.3.3 Neurostimulation Device Sales Analysis & Forecast
8.4 Liva Nova(Cyberonics)
  8.4.1 Business Overview
  8.4.2 Neurostimulation Products Portfolio
    8.4.2.1 VNS Therapy System
    8.4.2.2 VNS for the Treatment of Epilepsy
    8.4.2.3 VNS for the Treatment of TRD
    8.4.2.4 Liva Nova Neurostimulation Recent Developments
  8.4.3 Neurostimulation Device Sales Analysis & Forecast
8.5 Nevro
  8.5.1 Business Overview
  8.5.2 Neurostimulation Products Portfolio
    8.5.2.1 HF10 Therapy
    8.5.2.2 Senza System
  8.5.3 Neurostimulation Device Sales Analysis & Forecast

9. MARKET DRIVERS

9.1 Rapid Advancement in the Field of Neurostimulation Devices Market
9.2 Expansion of Indications Fuel the Growth of Neurostimulation Devices Market
9.3 Developing Markets Boon for the Manufacturers to Upsurge the Growth
9.4 Ageing Population & Life Expectancy Boost Growth for the Neurostimulation Market

10. MARKET BARRIERS

10.1 Unwillingness to Invasive Procedures of Deep Brain Stimulation
10.2 Regulatory Standards and Compliance Impede the Neurostimulation Devices Market
10.3 Negative Social Perception
10.4 Political Uncertainties
10.5 Healthcare Legislative Reform Measures Have Adversely Effected to the Manufacturers

List Of Tables

LIST OF TABLES

Table 3–1: By Segment – Neurostimulation Devices Market Share Outlook(Percent),2010 – 2015
Table 3–2: By Segment – Forecast for Neurostimulation Devices Market Share Outlook(Percent),2016 – 2021
Table 3–3: By Region – Neurostimulation Devices Market Share Outlook(Percent),2010 – 2015
Table 3–4: By Region – Forecast for Neurostimulation Devices Market Share Outlook(Percent),2016 – 2021
Table 3–5: By Application – Neurostimulation Devices Market Share Outlook(Percent),2010 – 2015
Table 3–6: By Application – Forecast for Neurostimulation Devices Market Share Outlook(Percent),2016 – 2021
Table 3–7: By Company – Neurostimulation Devices Market Share Outlook(Percent),2015 – 2021
Table 7–1: Neurostimulation Devices Market – Merger & Acquisitions (Million US$),2011 – 2016
Table 7–2: Neurostimulation Devices Market – Partnerships, Collaboration & Distribution Agreement,2009 – 2016

List Of Figures

LIST OF FIGURES

Figure 2 1: Global – Neurostimulation Devices Market (Million US$),2010 – 2015
Figure 2 2: Global – Forecast for Neurostimulation Devices Market (Million US$),2016 – 2021
Figure 4 1: By Segment - Neurostimulation Devices Market Revenue (Million US$),2010 – 2015
Figure 4 2: By Segment – Forecast for Neurostimulation Devices Market Revenue (Million US$),2016 – 2021
Figure 4 3: Global – Spinal Cord Stimulation Market Revenue (Million US$),2010 – 2015
Figure 4 4: Global – Forecast for Spinal Cord Stimulation Market Revenue (Million US$),2016 – 2021
Figure 4 5: Global – Deep Brain Stimulation Market Revenue (Million US$),2010 – 2015
Figure 4 6: Global – Forecast for Deep Brain Stimulation Market Revenue (Million US$),2016 – 2021
Figure 4 7: Global – Sacral Nerve Stimulation Market Revenue (Million US$),2010 – 2015
Figure 4 8: Global – Forecast for Sacral Nerve Stimulation Market Revenue (Million US$),2016 – 2021
Figure 4 9: Global – Vagus Nerve Market Revenue (Million US$),2010 – 2015
Figure 4 10: Global – Forecast for Vagus Nerve Market Revenue (Million US$),2016 – 2021
Figure 4 11: Global – Other Technologies Market Revenue (Million US$),2010 – 2015
Figure 4 12: Global – Forecast for Other Technologies Market Revenue (Million US$),2016 – 2021
Figure 5 1: Region wise – Neurostimulation Devices Market Revenue (Million US$),2010 – 2015
Figure 5 2: Region wise – Forecast for Neurostimulation Devices Market Revenue (Million US$),2016 – 2021
Figure 5 3: North America – Neurostimulation Devices Market Revenue (Million US$),2010 – 2015
Figure 5 4: North America – Forecast for Neurostimulation Devices Market Revenue (Million US$),2016 – 2021
Figure 5 5: Europe – Neurostimulation Devices Market Revenue (Million US$),2010 – 2015
Figure 5 6: Europe – Forecast for Neurostimulation Devices Market Revenue (Million US$), 2016 – 2021
Figure 5 7: Asia Pacific – Neurostimulation Devices Market Revenue (Million US$),2010 – 2015
Figure 5 8: Asia Pacific – Forecast for Neurostimulation Devices Market Revenue (Million US$),2016 – 2021
Figure 5 9: Latin America – Neurostimulation Devices Market Revenue (Million US$),2010 – 2015
Figure 5 10: Latin America – Forecast for Neurostimulation Devices Market Revenue (Million US$),2016 – 2021
Figure 5 11: ROW – Neurostimulation Devices Market Revenue (Million US$),2010 – 2015
Figure 5 12: ROW – Forecast for Neurostimulation Devices Market Revenue (Million US$),2016 – 2021
Figure 6 1: By Application – Neurostimulation Devices Market Revenue (Million US$),2010 – 2015
Figure 6 2: By Application – Forecast for Neurostimulation Devices Market Revenue (Million US$),2016 – 2021
Figure 6 3: Chronic Pain – Neurostimulation Devices Market Revenue (Million US$), 2010 – 2015
Figure 6 4: Chronic Pain – Forecast for Neurostimulation Devices Market Revenue (Million US$),2016 – 2021
Figure 6 5: Parkinson’s Disease – Neurostimulation Devices Market Revenue (Million US$),2010 – 2015
Figure 6 6: Parkinson’s Disease – Forecast for Neurostimulation Devices Market Revenue (Million US$),2016 – 2021
Figure 6 7: Urinary Fecal Incontinence – Neurostimulation Devices Market Revenue (Million US$),2010 – 2015
Figure 6 8: Urinary Fecal Incontinence – Forecast for Neurostimulation Devices Market Revenue (Million US$),2016 – 2021
Figure 6 9: Refractory Epilepsy – Neurostimulation Devices Market (Million US$),2010 – 2015
Figure 6 10: Refractory Epilepsy – Forecast for Neurostimulation Devices Market (Million US$),2016 – 2021
Figure 6 11: Essential Tremor – Neurostimulation Devices Market (Million US$),2010 – 2015
Figure 6 12: Essential Tremor – Forecast for Neurostimulation Devices Market (Million US$),2016 – 2021
Figure 6 13: Dystonia – Neurostimulation Devices Market (Million US$),2010 – 2015
Figure 6 14: Dystonia – Forecast for Neurostimulation Devices Market (Million US$),2016 – 2021
Figure 6 15: Gastroparesis – Neurostimulation Devices Market (Million US$),2010 – 2015
Figure 6 16: Gastroparesis – Forecast for Neurostimulation Devices Market (Million US$),2016 – 2021
Figure 6 17: TRD – Neurostimulation Devices Market (Million US$),2010 – 2015
Figure 6 18: TRD – Forecast for Neurostimulation Devices Market (Million US$),2016 – 2021
Figure 6 19: OCD – Neurostimulation Devices Market (Million US$),2010 – 2015
Figure 6 20: OCD – Forecast for Neurostimulation Devices Market (Million US$),2016 – 2021
Figure 6 21: Other Application – Neurostimulation Devices Market & Forecast (Million US$),2010 – 2015
Figure 6 22: Other Application – Forecast for Neurostimulation Devices Market & Forecast (Million US$),2016 – 2021
Figure 8 1: Medtronic – Neurostimulation Device Sales (Million US$),2010 – 2015
Figure 8 2: Medtronic – Forecast for Neurostimulation Device Sales (Million US$),2016 – 2021
Figure 8 3: Boston Scientific – Neurostimulation Device Sales (Million US$),2010 – 2015
Figure 8 4: Boston Scientific – Forecast for Neurostimulation Device Sales (Million US$),2016 – 2021
Figure 8 5: St Jude Medical – Neurostimulation Device Sales (Million US$),2010 – 2015
Figure 8 6: St Jude Medical – Forecast for Neurostimulation Device Sales (Million US$),2016 – 2021
Figure 8 7: Liva Nova – Neurostimulation Device Sales (Million US$),2010 – 2015
Figure 8 8: Liva Nova – Forecast for Neurostimulation Device Sales (Million US$),2016 – 2021
Figure 8 9: Nevro – Neurostimulation Device Sales (Million US$),2012 – 2015
Figure 8 10: Nevro – Forecast for Neurostimulation Device Sales (Million US$),2016 – 2021
Figure 9 1: Worldwide – Ageing Population & Forecast (Million), 2010 – 2050
Figure 9 2: Worldwide – Life Expectancy (Year), 1990 – 2012